Technology like this could expand further to form better collaborations between pharma, payers and organized providers.
Marketers survey the pluses and minuses of the platform's new 280-character limit.
Teva reports lower-than-expected Q3 earnings; BI and Dicerna partner in NASH drug development; AstraZeneca's experimental asthma drug fails in Phase-III
Do you recall what President Trump tweeted right after Merck's Kenneth Frazier resigned from his American Manufacturing Council?
The health startup's system has a foot scanner that can take photos of a patient's feet and can look for potential foot ulcers using a machine learning image classifier.
Two key creators from Ready Set Rocket share how a thoughtful execution can destigmatize mental illness.
AI complements what we in pharma have always done best — respond to medical needs quickly and find solutions.
The e-giant is reportedly doing everything from starting secret labs and online pharmacies to redefining the hospital experience and democratizing health data.
Some of the world's marketers have reported specific examples of where their digital advertising appeared alongside offensive and compromising content.
The CEO and founder of Antidote talks about what inspired him to start the company, which recently received funding from Merck.
Facebook itself has more than six million health-related groups.
Too few of the billions of sites online are usable for disabled people, says AudioEye's CEO.
The rise of voice technology platforms and the connected home has turned the discussion of a brand's voice from metaphorical to physical.
Facebook chief operating officer Sheryl Sandberg has said that in turbulent times the social network must do more than simply connect people.
Rosa talks about the wearable technology company's health and fitness plans and other areas of expansion.
Alexion to cut 600 jobs; Sage Therapeutics' experimental seizure drug fails to meet expectations; Apple is interested in medical and health activity
Teva names new CEO; Allergan transfers Restasis patent to skirt competition; Google invests in oncology
The coming digital revolution will change a lot of things, but I guarantee this: It won't replace the importance of the patient-physician relationship.
Consumers younger than the age of 45 were most likely to use an app developed by their health plan.
Alone among the best-known social platforms, Snapchat has failed to generate much enthusiasm from pharma. Here's why — and here's why that may change.
Calman is joining the technology company as VP of comms for Watson Health.
Facebook is ramping up its video offering as a stronger rival to YouTube and Snapchat with the launch of its redesigned video tab.
Patients are demanding more of their healthcare experience — and that includes from their healthcare providers, according to two new surveys.
Pharma has more or less ignored the social-blog hybrid Tumblr, with the number of programs using it countable on a single hand. That's about to change.
Celgene and Agios secure FDA approval for AML drug Idhifa; GSK hires chief digital and technology officer; Pfizer wants tax reform before M&A engagement
FDA launches digital health pre-certification pilot; J&J's experimental RA drug raises safety concerns; AstraZeneca gets breakthrough status for Imfinzi
Frustrated by its inability to empathize with patients, pharma has turned to tech to teach providers and caregivers what illness really feels like.
Novo Nordisk and Roche are two examples of drugmakers that are turning to digital-health startups to better engage with patients and mine valuable real-world evidence.
Publicis Health CEO Nick Colucci talks to MM&M about whether the AI tool will get U.S. and European creative directors to collaborate.
The Pikachu-catching phenomenon popularized AR and made the technology much more accessible.
AstraZeneca CEO reportedly moving to Teva; the FDA reverses on approval for Amicus drug; Merck names winners of Alexa challenge
Trump administration considers outcomes-based approach to lower drug prices; Sanofi to acquire vaccines biotech; Nestle partners with Enterome to develop microbiome-based diagnostics
Apple reportedly working to bring EMRs to iPhone; FDA to study disclosures in ads; Trump admin discussing drug price EO
Google invests in European biotechs; hospitals that restrict sales-rep visits more likely to prescribe cheaper generics; AI could help doctors with new research
The FDA-approved app will allow MS patients to share their medication injection history with HCPs.
Consent forms and reimbursement are the main deterrents of offering the service.
With physicians spending nearly four hours a day on their electronic health records, experts say voice assistants could help reduce their workload one day.
50% of consumers say they will share their health data with tech giants; pharma CEOs expect pricing proposal from Trump administration; FDA approves generic versions of Strattera
FDA presents ideas to tackle drug prices; patients aware of side effects more likely to report them; scientists use Apple's Research Kit for clinical purposes
Fitness trackers do not reliably track calories, docs find; health-tech startups face market uncertainty; FDA adcom votes in favor of Puma breast-cancer drug
Twitter has launched a customizable Direct Message Card that brands can use to promote and share the bots or other customer experiences they've created, while Snapchat and Instagram have launched stories updates.
The chip-in-a-pill combines antipsychotic Abilify with an ingestible sensor made by Proteus.
Siri and accessibility features take center stage in ads for Global Accessibility Awareness Day.
Robert Califf stepped down from his role as FDA commissioner in January.
FDA requires boxed warning for J&J's Invokana; Amazon to reportedly hire GM to enter pharmacy industry; WannCry ransomware affects some health organizations
To demonstrate the power of goggles equipped with AR and VR, the assistive technology company recreated the event on Facebook Live this weekend.
The artificial pancreas can provide value to the health system.
One executive referred to AI as a "black box" and as the "Tower of Babel."
In his keynote address at the MM&M Transforming Healthcare conference, Dr. Gautam Gulati says the industry is being outpaced by its innovation.
The market for health data and technology is growing, but the industry must also address concerns about privacy, standards, and diversity.
HHS Secretary Tom Price calls for health IT that works for clinicians and better interoperability.
Novartis, Kaiser, and Qualcomm partner on heart-failure pilot; Novartis and GSK disclose DTC plans; cancer-treatment hype can be negative for patients
Healthcare's collision with lower-cost genetic sequencing, mobile tech, AI, and consumerization will transform the trajectory of how we live for the next 10 years.
The device could be used by physicians to better understand the severity of a patient's symptoms and elicit empathy.
The drugmaker saw a gap in patient-physician conversation about retinal disease.
Gilead receives approval to market Harvoni, Sovaldi to adolescents; OncoMed ends mid-stage trials for pancreatic cancer drug; researchers use facial recognition software to diagnose
In the wake of MD Anderson's costly failure with IBM's Watson supercomputer, a Watson backlash brewing in biopharma may lead to a moment of reckoning in life sciences.
Susannah Fox is the former chief technology officer for HHS.
Dr. Mylene Yao is co-founder and CEO of Univfy.
Sam Frons is founder of Addicaid.
Stephanie Tilenius is CEO and co-founder of Vida Health.
Jenny Barnett is chief scientific officer at Cambridge Cognition.
Deborah Estrin is co-founder of Open mHealth.
Adrian Aoun is the CEO and founder of Forward.
John Lieberman is the founder of NYC Medtech.
Rick Altinger is CEO of Glooko.
Tom Kottler is co-founder and CEO of HealthPrize Technologies.
Dr. John Brownstein is cofounder of Circulation and chief innovation officer at Boston Children's Hospital.
Libbe Englander is founder and CEO of Pharm3r.
Brandi Davis-Dusenbery is CEO of Seven Bridges.
Dr. Amy Baxter is founder and CEO of MMJ Labs.
Dr. Robert Robbins is president and CEO of the Texas Medical Center.
Lynn O'Connor Vos is CEO of ghg.
Olivier Noel is founder and CEO of DNAsimple.
Thomas Goetz is the CEO and co-founder of Iodine.
Amy Molyneux is co-founder and EVP of Meta.
Melinda Richter is head of JLABS at Johnson & Johnson.
MM&M honors 40 upstarts and veteran innovation gurus.
Healthcare is one industry that hangs in this delicate balance, in large part due to the fact that it necessitates a blend of science and empathy.
This program is designed to enable entrepreneurs and biopharma marketers to engage in an intelligent way to explore beyond-the-pill partnerships.
As we build health solutions, making decisions in office parks and around conference tables, it's easy to lose the individual person through the scale of our work.
SXSW's health track finally got a seat at the big-kids table.
A high-profile cancer track commands attention, while wearables and IBM Watson Health come under fire.
The first days at SXSW Health went deep on entrepreneurship and the marketing thereof.
He instead decided to find a way to make a physician's job easier by creating a clinical messaging platform.
Gilead exec blames PBMs for high drug prices; Google uses AI to detect signs of breast cancer; Sanofi and Regeneron drug effective in treating eczema
The health insurer partnered with Microsoft to use VR and AR technology to gather biometric data.
Microsoft reenters healthcare market; Trump accuses Cummings of avoiding drug-pricing meeting; Trump says ACA replacement plan to be unveiled in March
The Kim Kardashian debacle aside, what makes the platform so potentially valuable to pharma and healthcare marketers is its visual story-telling capability.
Pharmaceutical and healthcare companies use a mix of corporate and brand accounts on Instagram, and some are turning to celebrity influencers.
A bout with Lyme disease led Yee to found a company that helps patients measure and track their breathing patterns.
Merck and Aetna partner in value-based drug pricing; data scientists rising in the biopharma ranks; Japanese pharma leads digital health innovation
Transportation barriers can limit patient involvement in clinical trials.
Novartis forecasts slower growth in 2017; Actelion reports trial failure for PAH drug; HHS nominee Tom Price denies conflict of interest claims
Rep. Price to answer questions at confirmation hearing; 22 drugmakers invest in fighting disease in poor countries; FDA approves generic of Jazz's Xyrem
There are dozens of players, including leaders like IBM Watson Health and Verily as well as smaller concerns, lining up to sell pharma access to some sort of data solution.
Nothing is more personal than an individual's health; the technology that will prove most effective will be solutions that are personal.
Illumina and IBM enter DNA sequencing partnership; J&J to outline price increases in new report; Egalet's opioid Arymo ER gets FDA approval
Otsuka, Astellas, Takeda, and Daiichi Sankyo share a degree of adventurousness and forward-mindedness in the digital realm.
This month we will debut a restyled MM&M logo on our website, in a mobile-friendly, redesigned email newsletter, and on the cover of our magazine.